Clinical and technological transition in breast cancer

Philip Poortmans; Hugo Marsiglia; Manuel De Las Heras; Manuel Algara

doi:10.1016/j.rpor.2013.08.002

Clinical and technological transition in breast cancer

Rep Pract Oncol Radiother. 2013 Sep 9;18(6):345-52. doi: 10.1016/j.rpor.2013.08.002.

Authors

Philip Poortmans¹, Hugo Marsiglia², Manuel De Las Heras³, Manuel Algara⁴

Affiliations

¹ Radiotherapy Department, Institute Verbeeten, Tilburg, The Netherlands.
² Radiotherapy Department, Instituve Gustave Roussy, Villejuif, France.
³ Radiotherapy Department, Hospital Clínico San Carlos, Madrid, Spain.
⁴ Radiotherapy Department, Parc de Salut Mar, Barcelona, Spain.

Abstract

This article is a summary of the conference "Clinical and technological transition in breast cancer" that took place in the Congress of the Spanish Society of Radiation Oncology, placed in Vigo (Spain) on June 21, 2013. Hugo Marsiglia and Philip Poortmanns were the speakers, the first discussed about "Clinical and technological transition" and the second about "EORTC clinical trials and protocols".

Keywords: Breast cancer; Clinical trial; Radiotherapy; Technological.

Publication types

Review